Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: A comparison with TNF-α genetic deletion

Shock

Volumn 27, Issue 5, 2007, Pages 542-551

  Malleo, Giuseppe ^a   Mazzon, Emanuela ^a   Genovese, Tiziana ^a,b   Di Paola, Rosanna ^a,b   Muià, Carmelo ^a   Centorrino, Tommaso ^a   Siriwardena, Ajith K ^c   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Apoptosis; Biological therapy; Knockout mice; Neutrophils infiltration

Indexed keywords

AMYLASE; CERULETIDE; ETANERCEPT; MYELOPEROXIDASE; SODIUM CHLORIDE; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; WATER;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GENE DELETION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INHIBITION KINETICS; MOUSE; MOUSE STRAIN; NICK END LABELING; NONHUMAN; PANCREAS; PANCREAS NECROSIS; PHARMACOLOGICAL BLOCKING; RECEPTOR GENE; TISSUE LEVEL; WATER CONTENT;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; CAERULEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; GENE DELETION; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOTOXIN-ALPHA; MICE; MICE, KNOCKOUT; P-SELECTIN; PANCREATITIS; PEROXIDASE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34047232622     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000246900.50445.1d     Document Type: Article

References (41)

1. Working Party of the British Society of Gastroenterology, Association of Surgeons of Great Britain and Ireland, Pancreatic Society of Great Britain and Ireland, and Association of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut 54:1-9, 2005.
2. Granger J, Remick D: Acute pancreatitis: models, markers, and mediators. Shock 24:45-51, 2005.
3. Hirota M, Nozawa F, Okabe A, Shibata M, Beppu T, Shimada S, Egami H, Yamaguchi Y, Ikei S, Okajima T, et al.: Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 21:141-146, 2000.
4. Norman JG, Fink GW, Franz MG: Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 130:966-970, 1995.
5. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L: Pathophysiology of acute pancreatitis. Pancreatology 5:132-144, 2005.
6. Hughes CB, Grewal HP, Gaber LW, Kotb M, El-din AB, Mann L, Gaber AO: Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg 171:274-280, 1996.
7. Oruc N, Ozutemiz O, Yukelsen V, Nart D, Celik HA, Yuce G, Batur Y: Infliximab: a new therapeutic agent in acute pancreatitis? Pancreas 28:1-8, 2004.
8. Schafer C, Tietz AB, Goke B: Pathophysiology of acute experimental pancreatitis: lessons from genetically engineered animal models and new molecular approaches. Digestion 71:162-172, 2005.
9. Denham W, Yang J, Norman J: Evidence for an unknown component of pancreatic ascites that induces adult respiratory distress syndrome through an interleukin-1 and tumor necrosis factor-dependent mechanism. Surgery 122:295-301, 1997.
10. Denham W, Yang J, Fink G, Denham D, Carter G, Ward K, Norman J: Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology 113:1741-1746, 1997.
11. Douni E, Kollias G: A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R. J Exp Med 188:1343-1352, 1998.
12. Granell S, Pereda J, Gomez-Cambronero L, Cassinello N, Sabater L, Closa D, Sastre J: Circulating TNF-alpha and its soluble receptors during experimental acute pancreatitis. Cytokine 25:187-191, 2004.
13. de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC: Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 83:349-353, 1996.
14. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 89:4845-4849, 1992.
15. Yung RL: Etanercept Immunex. Curr Opin Investig Drugs 2:216-221, 2001.
16. Pugsley MK: Etanercept Immunex. Curr Opin Investig Drugs 2:1725-1731, 2001.
17. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann ER, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, et al.: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337:141-147, 1997.
18. Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann ER, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, et al.: Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 130:478-486, 1999.
19. Gorman JD, Sack KE, Davis JC Jr: Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 346:1349-1356, 2002.
20. Mease PJ, Goffe BS, Metz J, Van der Stoep A, Finck B, Burge DJ: Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356:385-390, 2000.
21. Papp KA, Tyring S, Lahfa M, Prinz J, Griffiths CE, Nakanishi AM, Zitnik R, van de Kerkhof PC, Melvin L, for the Etanercept Psoriasis Study Group: A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol 152:1304-1312, 2005.
22. Genovese T, Mazzon E, Di Paola R, Muià C, Crisafulli C, Malleo G, Esposito E, Cuzzocrea S: Role of endogenous Peroxisome Proliferators Activated Receptors alpha (PPAR-α) ligands in the development of acute pancreatitis induced by cerulein. Immunology 118:559-570, 2006.
23. Genovese T, Mazzon E, Di Paola R, Muia C, Crisafulli C, Menegazzi M, Malleo G, Suzuki H, Cuzzocrea S: Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice. Shock 25:161-167, 2006.
24. Cuzzocrea S, Genovese T, Mazzon E, Di Paola R, Muia C, Britti D, Salvemini D: Reduction in the development of cerulein-induced acute pancreatitis by treatment with M40401, a new selective superoxide dismutase mimetic. Shock 22:254-261, 2004.
25. Gukovskaya AS, Pandol SJ: Cell death pathways in pancreatitis and pancreatic cancer. Pancreatology 4:567-586, 2004.
26. Denham W, Fink G, Yang J, Ulrich P, Tracey K, Norman J: Small molecule inhibition of tumor necrosis factor gene processing during acute pancreatitis prevents cytokine cascade progression and attenuates pancreatitis severity. Am Surg 63:1045-1049, 1997.
27. Hirano T: Cytokine suppressive agent improves survival rate in rats with acute pancreatitis of closed duodenal loop. J Surg Res 81:224-229, 1999.
28. Gomez-Cambronero L, Camps B, de La Asuncion JG, Cerda M, Pellin A, Pallardo FV, Calvete J, Sweiry JH, Mann GE, Vina J, et al.: Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide. J Pharmacol Exp Ther 293:670-676, 2000.
29. Marton J, Farkas G, Takacs T, Nagy Z, Szasz Z, Varga J, Jarmay K, Balogh A, Lonovics J: Beneficial effects of pentoxifylline treatment of experimental acute pancreatitis in rats. Res Exp Med 197:293-299, 1998.
30. Pereda J, Sabater L, Cassinello N, Gòmez-Cambronero L, Closa D, Folch-Puy E, Aparisi L, Calvete J, Cerdà M, Lledò S, et al.: Effect of simultaneous inhibition of TNF-alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases. Ann Surg 240:108-116, 2004.
31. Grewal HP, Mohey el Din A, Gaber L, Gaber L, Kotb M, Gaber AO: Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg 67:214-218, 1994.
32. Hughes CB, Gaber LW, Mohey el-Din AB, Grewal HP, Kotb M, Mann L, Gaber AO: Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg 62:8-13, 1996.
33. Norman JG, Fink GW, Messina J, Carter G, Franz MG: Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 120:515-521, 1996.
34. Grounds MD, Davies M, Torrisi J, Shavlakadze T, White J, Hodgetts S: Silencing TNF-alpha activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice. Cell Tissue Res 320:509-515, 2005.
35. Kadl A, Leitinger N: The role of endothelial cells in the resolution of acute inflammation. Antioxid Redox Signal 7:1744-1754, 2005.
36. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Centorrino T, Ciccolo A, Van de Loo FA, Britti D, Caputi AP, Thiemermann C: Inducible nitric oxide synthase-deficient mice exhibit resistance to the acute pancreatitis induced by cerulein. Shock 17:416-422, 2002.
37. Friess H, Lu Z, Riesle E, Uhl W, Brundler AM, Horvath L, Gold LI, Korc M, Buchler MW: Enhanced expression of TGF-betas and their receptors in human acute pancreatitis. Ann Surg 227:95-104, 1998.
38. Gress T, Muller-Pillasch F, Elsasser HP, Bachem M, Ferrara C, Weidenbach H, Lerch M, Adler G: Enhancement of transforming growth factor beta 1 expression in the rat pancreas during regeneration from caerulein-induced pancreatitis. Eur J Clin Invest 24:679-685, 1994.
39. Yoo BM, Yeo M, Oh TY, Choi JH, Kim WW, Kim JH, Cho SW, Kim SJ, Hahm KB: Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling. Pancreas 30:71-79, 2005.
40. Mentula P, Kylanpaa ML, Kemppainen E, Eklund KK, Orpana A, Puolakkainen P, Haapiainen R, Repo H: Serum levels of mast cell tryptase, vascular endothelial growth factor and basic fibroblast growth factor in patients with acute pancreatitis. Pancreas 27:29-33, 2003.
41. Gomez G, Lee HM, He Q, Englander EW, Uchida T, Greeley GH Jr: Acute pancreatitis signals activation of apoptosis-associated and survival genes in mice. Exp Biol Med 226:692-700, 2001.